EOM PHARMACEUTICAL HLDNGS lost $1.23 per diluted share in fiscal year 2017. Over the trailing 12 months, Q3 FY2017 through Q2 FY2018, the same line adds up to $0.47 per diluted share. The table below carries 13 fiscal years, from 2005 to 2017, and the quarters EOM PHARMACEUTICAL HLDNGS has filed alongside them.
FY2017 annual
EPS (Diluted)-$1.23
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2018, ended Jun 30, 2018ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
IMUC EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was EOM PHARMACEUTICAL HLDNGS's diluted earnings per share in fiscal year 2017?
EOM PHARMACEUTICAL HLDNGS lost $1.23 per diluted share in fiscal year 2017.
What is EOM PHARMACEUTICAL HLDNGS's diluted earnings per share over the last twelve months?
EOM PHARMACEUTICAL HLDNGS (IMUC) reported $0.47 per diluted share over the trailing 12 months, Q3 FY2017 through Q2 FY2018, summed from the four most recent quarterly filings.
What was EOM PHARMACEUTICAL HLDNGS's diluted earnings per share in the most recent quarter?
EOM PHARMACEUTICAL HLDNGS (IMUC) reported -$0.01 in diluted earnings per share in Q2 2018.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what EOM PHARMACEUTICAL HLDNGS (IMUC) reported on that line in every period on record.
